N,N′,N″-triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in Escherichia coli sepsis in dogs

Critical Care Medicine

Volumn 32, Issue 1, 2004, Pages 184-193

  Mink, Steven N ^a,b   Jacobs, Hans ^a   Duke, Krika ^a   Bose, Deepak ^a   Cheng, Zhao Quin ^a   Light, R Bruce ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Chitotriose; Endotoxemia; Glycoproteins; Left ventricular depression; Myocardial depressant factor; N,N ,N triacetylchitotriose; Septic shock; Stroke work

Indexed keywords

ENZYME INHIBITOR; GLUCOSAMINE DERIVATIVE; LYSOZYME; LYSOZYME INHIBITOR; MIDAZOLAM; N ACETYLGLUCOSAMINE; N,N' DIACETYLGLUCOSAMINE; N,N',N'' TRIACETYLGLUCOSAMINE; N,N',N'',N''' TETRAACETYLGLUCOSAMINE; OLIGOSACCHARIDE; PLACEBO; SUFENTANIL CITRATE; THIOPENTAL; UNCLASSIFIED DRUG; ACETYLGLUCOSAMINIDASE; HEART MUSCLE DEPRESSANT FACTOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG EFFECT; ESCHERICHIA COLI; GRAM NEGATIVE SEPSIS; HEART FUNCTION; HEART STROKE VOLUME; MYOCARDIAL DEPRESSION; MYOCARDIAL DISEASE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; SHOCK; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; ENTEROBACTER INFECTION; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; MALE; METABOLISM; PROBABILITY; RANDOMIZATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK;

ACETYLGLUCOSAMINIDASE; ANIMALS; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; DOGS; ESCHERICHIA COLI INFECTIONS; FEMALE; MALE; MURAMIDASE; MYOCARDIAL CONTRACTION; MYOCARDIAL DEPRESSANT FACTOR; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1342330592     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000104919.07538.04     Document Type: Article

References (30)

1. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
2. Lefer A, Rovetto M: Influence of a myocardial depressant factor on physiologic properties of cardiac muscle. Proc Soc Exp Biol 1970; 134:269-273
3. Lefer A, Cowgill R, Marshall F, et al: Characterization of a myocardial depressant factor present in hemorrhagic shock. Am J Physiol 1967; 213:492-498
4. Parrillo J, Burch C, Shelhamer J, et al: A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 1985; 76:1539-1553
5. Mink SN, Jacobs H, Bose D, et al: Lysozyme: A mediator of myocardial depression and adrenergic dysfunction in septic shock in dogs. J Mol Cell Cardiol 2003; 35:265-275
6. Fleming A: On a remarkable bacteriolytic element found in tissue and secretions. Proc R Soc Lond (Biol) 1922; 93:306-307
7. Chipman DM, Sharon N: Mechanism of lysozyme action. Science 1965; 165:454-465
8. Rand-Meir T, Dahlquist FW, Raftery MA: Use of synthetic substrates to study binding and catalysis by lysozyme. Biochemistry 1969; 8:4206-4214
9. Briggs RS, Perillie PE, Finch SC: Lysozyme in bone marrow and peripheral blood cells. J Histochem Cytochem 1969; 14:167-170
10. Hansen NE, Andersen V: Lysozyme activity in human neutrophilic granulocytes. Br J Haematol 1973; 24:613-623
11. Hansen NE, Karle H, Andersen V, et al: Lysozyme turnover in man. J Clin Invest 1972; 51:1146-1155
12. Gomez A, Wang R, Unruh H, et al: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73:671-685
13. Rademacher TW, Parekh RB, Dwek RA: Glycobiology. Ann Rev Biochem 1988; 57: 785-838
14. National Institutes of Health. Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23). Bethesda, MD, National Institutes of Health, 1996
15. Flecknell, P. Laboratory Animal Anaesthesia. Second Edition. San Diego, CA, Academic Press, 1996
16. Chrusch C, Bands C, Bose D, et al: Impaired hepatic extraction and increased splanchnic production contribute to lactic acidosis in canine sepsis. Am J Respir Crit Care Med 2000; 161:517-526
17. Mink SN, Li X, Bose D, et al: Early but not delayed continuous arteriovenous hemofiltration improves cardiovascular function in sepsis in dogs. Intensive Care Med 1999; 25:733-743
18. Li X, Eschun G, Bose D, et al: Histamine H3 activation depresses cardiac function in experimental sepsis. J Appl Physiol 1998; 85: 1693-1701
19. Maley F, Trimble RB, Tarentino AL, et al: Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 1989; 80:195-204
20. Grobler JA, Rao R, Pervaiz S, et al: Sequences of two highly divergent canine type c lysozymes: Implications for the evolutionary origins of the lysozyme/α-lactalbumin superfamily. Archives Biochem Biophys 1994; 313: 360-366
21. Jha P, Jacobs H, Bose D, et al: Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dog ventricle. Am J Physiol 1993; 264(Heart Circ Physiol 33):H1402-H1410
22. Gu M, Bose R, Bose D, et al: Tumour necrosis factor-α, but not septic plasma depresses cardiac myofilament contraction. Can J Anaesth 1998; 45:352-359
23. Morris AJ, Malbon CC: Physiological regulation of G protein signaling. Physiol Rev 1999; 79:1373-1430
24. Henning U, Wolf WP, Holtzhauer M: Primary cultures of cardiac muscle cells as models for investigation of protein glycosylation. Mol Cell Biochem 1996; 160-161:41-46
25. Ufret-Vincenty CA, Baro DJ, Santana LF: Differential contribution of sialic acid to the function of repolarization K (+) currents in ventricular myocytes. Am J Physiol Cell Physiol 2001; 281:C464-C474
26. Bennett ER: Effects of channel cytoplasmic regions on the activation mechanisms of cardiac versus skeletal muscle Na+ channels. Biophys J 1999; 77:2999-3009
27. Burgess P, Appel SH, Wilson CA, et al: Detection of intra-abdominal abscess by serum lysozyme estimation. Surgery 1994; 115:16-21
28. Prewitt RM, Wood LDH: Effect of altered resistive afterload on left ventricular systolic mechanics in dogs. Anesthesiology 1982; 56: 195-202
29. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
30. McDonald TE, Grinman MN, Carthy CM, et al: Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol (Heart Circ Physiol) 2000; 279:H2053-H2061